These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31319151)

  • 21. Ocular Fluid Mechanics and Drug Delivery: A Review of Mathematical and Computational Models.
    Bhandari A
    Pharm Res; 2021 Dec; 38(12):2003-2033. PubMed ID: 34936067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacokinetics of the anterior eye].
    Bell K; Pfeiffer N; Grus FH
    Ophthalmologe; 2014 Feb; 111(2):107-12. PubMed ID: 24337342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ocular delivery systems for topical application of anti-infective agents.
    Duxfield L; Sultana R; Wang R; Englebretsen V; Deo S; Rupenthal ID; Al-Kassas R
    Drug Dev Ind Pharm; 2016 Jan; 42(1):1-11. PubMed ID: 26325119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular tissue distribution and pharmacokinetic study of a small 13kDa domain antibody after intravitreal, subconjuctival and eye drop administration in rabbits.
    Gough G; Szapacs M; Shah T; Clements P; Struble C; Wilson R
    Exp Eye Res; 2018 Feb; 167():14-17. PubMed ID: 29074387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limits on optimizing ocular drug delivery.
    Keister JC; Cooper ER; Missel PJ; Lang JC; Hager DF
    J Pharm Sci; 1991 Jan; 80(1):50-3. PubMed ID: 2013850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microengineered biomimetic ocular models for ophthalmological drug development.
    Estlack Z; Bennet D; Reid T; Kim J
    Lab Chip; 2017 May; 17(9):1539-1551. PubMed ID: 28401229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a physiologically-based pharmacokinetic model for ocular disposition of monoclonal antibodies in rabbits.
    Bussing D; K Shah D
    J Pharmacokinet Pharmacodyn; 2020 Dec; 47(6):597-612. PubMed ID: 32876799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent developments in ocular drug delivery.
    Chen H
    J Drug Target; 2015; 23(7-8):597-604. PubMed ID: 26453157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of topically applied tacrolimus dissolved in Marinosolv, a novel aqueous eye drop formulation.
    Siegl C; König-Schuster M; Nakowitsch S; Koller C; Graf P; Unger-Manhart N; Schindlegger Y; Kirchoff N; Knecht C; Prieschl-Grassauer E; Sipos W
    Eur J Pharm Biopharm; 2019 Jan; 134():88-95. PubMed ID: 30465821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical Ocular Delivery of TGF-β1 to the Back of the Eye: Implications in Age-Related Neurodegenerative Diseases.
    Platania CBM; Fisichella V; Fidilio A; Geraci F; Lazzara F; Leggio GM; Salomone S; Drago F; Pignatello R; Caraci F; Bucolo C
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28973964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular and systemic bioavailability of ophthalmic flurbiprofen.
    Tang-Liu DD; Liu SS; Weinkam RJ
    J Pharmacokinet Biopharm; 1984 Dec; 12(6):611-26. PubMed ID: 6533296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of the African green monkey as a preclinical model for ocular pharmacokinetic studies.
    Glogowski S; Ward KW; Lawrence MS; Goody RJ; Proksch JW
    J Ocul Pharmacol Ther; 2012 Jun; 28(3):290-8. PubMed ID: 22235843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular disposition, pharmacokinetics, efficacy and safety of nanoparticle-formulated ophthalmic drugs.
    Bu HZ; Gukasyan HJ; Goulet L; Lou XJ; Xiang C; Koudriakova T
    Curr Drug Metab; 2007 Feb; 8(2):91-107. PubMed ID: 17305490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement in Ocular Bioavailability and Prolonged Delivery of Tobramycin Sulfate Following Topical Ophthalmic Administration of Drug-Loaded Mucoadhesive Microparticles Incorporated in Thermosensitive In Situ Gel.
    Khan S; Warade S; Singhavi DJ
    J Ocul Pharmacol Ther; 2018 Apr; 34(3):287-297. PubMed ID: 29211593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocular Distribution and Pharmacokinetics of Lifitegrast in Pigmented Rabbits and Mass Balance in Beagle Dogs.
    Chung JK; Spencer E; Hunt M; McCauley T; Welty D
    J Ocul Pharmacol Ther; 2018; 34(1-2):224-232. PubMed ID: 29267138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population Pharmacokinetic Modeling of Azithromycin Eyedrops in Tears Following Single-Dose Topical Administration in Healthy Volunteers.
    Wu F; Zhao X; Li X; Cui Y
    Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):371-378. PubMed ID: 30357610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.
    Jiao J
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1663-73. PubMed ID: 18845195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled and continuous release ocular drug delivery systems: pros and cons.
    Abdelkader H; Alany RG
    Curr Drug Deliv; 2012 Jul; 9(4):421-30. PubMed ID: 22640036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic adverse effects of topical ocular treatments.
    Labetoulle M; Frau E; Le Jeunne C
    Presse Med; 2005 Apr; 34(8):589-95. PubMed ID: 15962500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative Study of Ocular Pharmacokinetics of Gatifloxacin Between Continuous Lavage and Hourly Topical Instillation in Rabbits.
    Zhao X; Shen X; Zhang X; Chen S; Lu H; Wang M
    Cornea; 2018 Nov; 37(11):1457-1462. PubMed ID: 30124589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.